desvenlafaxine tablet film coated extended release
1 INDICATIONS AND USAGE Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies ( 14 )]. Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).
west-ward pharmaceuticals corp.
ROUND BROWN 54 427
54 427 ROUND BROWN
Related Pills
24 HR desvenlafaxine succinate 50 MG Extended Release Oral Tablet
West-Ward Pharmaceuticals Corp.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
DESVENLAFAXINE Extended-Release Tablets 25 mg tablet is supplied as a beige film-coated, standard biconvex tablet debossed with “54” [above] “427” on one side and plain on the other side. Each tablet contains 38 mg of
DESVENLAFAXINE succinate equivalent to 25 mg of
DESVENLAFAXINE. NDC 0054-0603-13: Bottle of 30 Tablets Unit-of-use 50 mg tablet is supplied as a peach film-coated, standard biconvex tablet debossed with “54” [above] “716” on one side and plain on the other side. Each tablet contains 76 mg of
DESVENLAFAXINE succinate equivalent to 50 mg of
DESVENLAFAXINE. NDC 0054-0400-06: Bottle of 14 Tablets Unit-of-use NDC 0054-0400-13: Bottle of 30 Tablets Unit-of-use NDC 0054-0400-22: Bottle of 90 Tablets Unit-of-use NDC 0054-0400-29: Bottle of 500 Tablets NDC 0054-0400-20: Carton of 100 (10x10) Unit-Dose Tablets 100 mg tablets are supplied as orange film-coated, standard biconvex tablet debossed with “54 [above] 341” on one side and plain on the other side. Each tablet contains 152 mg of
DESVENLAFAXINE succinate equivalent to 100 mg of
DESVENLAFAXINE. NDC 0054-0401-06: Bottle of 14 Tablets Unit-of-use NDC 0054-0401-13: Bottle of 30 Tablets in Unit-of-use NDC 0054-0401-22: Bottle of 90 Tablets in Unit-of-use NDC 0054-0401-20: Carton of 100 (10x10) Unit-Dose Tablets Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.] The unit-of-use package is intended to be dispensed as a unit.
More pills like ROUND 54 427